Dissemin is shutting down on January 1st, 2025

Published in

Bentham Science Publishers, Current Pharmaceutical Design, 19(24), p. 2188-2207, 2018

DOI: 10.2174/1381612824666180516103609

Links

Tools

Export citation

Search in Google Scholar

Polyphenols, their metabolites and derivatives as drug leads

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

In this non-comprehensive review, the potential of natural polyphenols as lead compounds for the design and synthesis of new molecules with potential application in several diseases was highlighted. Organic synthesis has been essential for the development of new analogues of naturally found polyphenols, providing a wide range of structural modifications for structure-activity relationship studies and improving or modulating the biological activity of the promising compounds.